文献速递慢性肾脏病

慢性肾脏病中的绝经问题

Menopause in CKD.
PubMed 文献 · Am J Kidney Dis · 2018-03-09

综述指出,所有CKD分期(3-5D期)均报告绝经提前,但传统绝经定义在CKD 5D期不适用,因激素替代治疗或肾移植后月经可恢复。血管舒缩症状仍是激素替代治疗的主要指征,但尚无针对CKD或肾移植人群的剂量研究。绝经对CKD/肾移植患者心血管疾病和骨质疏松风险的额外影响尚待探索,缺乏数据和具体管理指南使绝经长期影响成为临床肾脏病学最被忽视的患者问题之一。

要点

  • 所有CKD分期均报告绝经提前,但CKD 5D期传统绝经定义不适用。
  • 激素替代治疗CKD人群无专门剂量研究,血管舒缩症状仍是主要指征。
  • 绝经对CKD/肾移植心血管和骨质疏松风险的额外作用尚待探索。

核心结论

  • 缺乏数据和具体管理指南使绝经长期影响成为临床肾脏病学最被忽视和忽视的患者问题之一。

研究设计与样本

  • 综述,未报告系统检索范围。

主要发现

  • 所有CKD分期(3-5D期)均报告绝经提前。
  • 传统绝经定义在CKD 5D期不适用,因激素替代治疗或肾移植后月经可恢复。
  • 血管舒缩症状仍是激素替代治疗的主要指征,但无针对CKD或肾移植人群的剂量研究。
  • 绝经对CKD/肾移植患者心血管疾病和骨质疏松风险的额外作用尚待探索。

临床怎么用

  • 临床应关注CKD各期女性绝经提前问题。
  • CKD 5D期女性不应简单套用传统绝经定义。
  • 对CKD/肾移植患者绝经相关治疗需谨慎,因缺乏专门剂量研究。

局限性

  • 缺乏针对CKD和肾移植人群的绝经管理数据和具体指南。
  • 尚无纵向临床试验明确CKD中绝经定义及相互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Most women with dialysis-dependent chronic kidney disease (CKD) stage 5 (CKD stage 5D) are in the postmenopausal age group. Early menopause is reported for all CKD stages (stages 3-5D). The traditional definition of menopause is not applicable in CKD stage 5(D) because menses can resume with hormone replacement therapy or kidney transplantation. Treatment of vasomotor symptoms continues to be the primary indication for hormone replacement therapy, with no dosing studies done specifically for CKD or kidney transplantation populations. Similarly, the risk for cardiovascular disease and osteoporosis in menopause is well described in healthy women, but the role that menopause plays in accelerating the risk further in CKD/kidney transplantation is yet to be explored. Lack of data and specific guidance on management make the long-term effects of menopause one of the most under-recognized and neglected patient problems in clinical nephrology. The efficacy and side effects of widely available therapeutic options in healthy women for menopause-related clinical manifestations, be it hormone replacement therapy for vasomotor symptoms or antiresorptive agents for osteoporosis, are to be tested in kidney transplantation and CKD populations. Longitudinal clinical trials are in need to define menopause in CKD and determine the role that CKD plays in menopause transition and menopause on CKD manifestations.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Vellanki K, Hou S. Menopause in CKD. Am J Kidney Dis. 2018. PMID: 29530509. doi:10.1053/j.ajkd.2017.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。